Abstract

HomeCirculation: Cardiovascular Quality and OutcomesVol. 16, No. 4Correction to: Examination of Sexual Identity Differences in the Prevalence of Hypertension and Antihypertensive Medication Use Among US Adults: Findings From the Behavioral Risk Factor Surveillance System Free AccessCorrectionPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessCorrectionPDF/EPUBCorrection to: Examination of Sexual Identity Differences in the Prevalence of Hypertension and Antihypertensive Medication Use Among US Adults: Findings From the Behavioral Risk Factor Surveillance System Originally published18 Apr 2023https://doi.org/10.1161/HCQ.0000000000000116Circulation: Cardiovascular Quality and Outcomes. 2023;16This article corrects the followingExamination of Sexual Identity Differences in the Prevalence of Hypertension and Antihypertensive Medication Use Among US Adults: Findings From the Behavioral Risk Factor Surveillance SystemIn the article by Caceres et al, “Examination of Sexual Identity Differences in the Prevalence of Hypertension and Antihypertensive Medication Use Among US Adults: Findings From the Behavioral Risk Factor Surveillance System”, which initially published online December 21, 2022 (Circulation: Cardiovascular Quality and Outcomes. 2022;15: e00899. DOI: 10.1161/CIRCOUTCOMES.122.008999), corrections are needed.On page 954 the sentence “In 2014, an optional sexual orientation and sex identity module was introduced to the BRFSS” should read “In 2014, an optional sexual orientation and gender identity module was introduced to the BRFSS.”On page 954 the sentence “Given that this analysis focused on sexual identity differences in the prevalence of hypertension and antihypertensive medication use among cisgender (ie, individuals whose sex identity aligns with their sex assigned at birth) adults, we next excluded participants with missing data for the sex identity item (n=1635) as well as those who self-identified as gender minorities (ie, transgender or gender non-binary nonbinary; n=1636)” should read “Given that this analysis focused on sexual identity differences in the prevalence of hypertension and antihypertensive medication use among cisgender (ie, individuals whose gender identity aligns with their sex assigned at birth) adults, we next excluded participants with missing data for the gender identity item (n=1635) as well as those who self-identified as gender minorities (ie, transgender or gender nonbinary; n=1636).”.On page 961 the sentence “Findings are not nationally representative as the optional sexual orientation and sex identity module in the BRFSS was only used by 22 states in 2015, 27 states in 2017, and 31 states in 2019” should read “Findings are not nationally representative as the optional sexual orientation and gender identity module in the BRFSS was only used by 22 states in 2015, 27 states in 2017, and 31 states in 2019.”On page 961 the sentence “Thus, findings may not be generalizable to sexual minority adults living in states that did not include the BRFSS optional sexual orientation and sex identity module during these years” should read “Thus, findings may not be generalizable to sexual minority adults living in states that did not include the BRFSS optional sexual orientation and gender identity module during these years.”The publisher regrets these errors.This correction has been made to the current version of the article, which is available at https://www.ahajournals.org/doi/10.1161/CIRCOUTCOMES.122.008999. Previous Back to top Next FiguresReferencesRelatedDetailsRelated articlesExamination of Sexual Identity Differences in the Prevalence of Hypertension and Antihypertensive Medication Use Among US Adults: Findings From the Behavioral Risk Factor Surveillance SystemYashika Sharma, et al. Circulation: Cardiovascular Quality and Outcomes. 2022;15 April 2023Vol 16, Issue 4 Advertisement Article InformationMetrics © 2023 American Heart Association, Inc.https://doi.org/10.1161/HCQ.0000000000000116PMID: 37071724 Originally publishedApril 18, 2023 PDF download Advertisement

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.